ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1429	National Cancer Institute	Html	en	Neuroblastoma Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for neuroblastoma.	cancer treatment 0.486632 cancer screening methods 0.582299 ongoing clinical trials 0.502871 neuroblastoma 0.698844 PDQ cancer information 0.80843 false-negative test result 0.502128 NCI Web site 0.507263 clinical trials 0.709878 vanillyl mandelic acid 0.576656 test result 0.623055 nerve tissue 0.489507 cancer information summary 0.657568 clinical trial 0.522829 breast cancer prevention 0.512391 diagnostic tests 0.506931 test results 0.491146 false-positive test result 0.501632 PDQ summaries 0.524226 latest published information 0.506403 PDQ® Screening 0.491512 NCI’s PDQ 0.527909 cancer symptoms 0.501892 NCI PDQ cancer 0.598105 PDQ Neuroblastoma Screening 0.65982	tests 0.548148 routine screening test 0.556554 Neuroblastoma Treatment 0.531296 new cases 0.489109 PDQ Screening 0.567089 screening tests 0.516882 homovanillic acid 0.494688 Cancer Information Service 0.531924 urine test result 0.504837 Prevention Editorial Board 0.562279 treatment clinical trials 0.501764 National Cancer Institute 0.643496 PDQ documents 0.515811 new treatment 0.51605 health professional version 0.484258 Cancer screening trials 0.58895 PDQ database 0.522175 Cancer Care page 0.516301 adrenal glands 0.539844 PDQ summary 0.591543 cancer information summaries 0.540208 health professional versions 0.487782 comprehensive cancer information 0.541053 cancer 0.90999	CLICK HERE
1442	National Cancer Institute	Html	en	Cancer Genetics Risk Assessment and Counseling (PDQ®)–Health Professional Version	Expert-reviewed information summary in which cancer risk perception, risk communication, and risk counseling are discussed. The summary also contains information about recording and analyzing a family history of cancer and factors to consider when offering genetic testing.	founder pathogenic variants 0.545253 empiric cancer risk 0.604134 cancer family histories 0.596956 cancer history data 0.547429 family cancer history 0.660687 BRCA1/BRCA2 genetic testing 0.54809 cancer risk management 0.587191 pathogenic variant probability 0.552774 hereditary cancer syndromes 0.558149 individual cancer risk 0.61901 hereditary cancer syndrome 0.566539 risk factors 0.556301 colorectal cancer 0.654372 pathogenic variant 0.790487 pathogenic variant risk 0.567786 ovarian cancer 0.54855 cancer risk assessment 0.697386 genetic cancer risk 0.622505 specific cancer risk 0.6007 relative risk 0.558342 cancer genetic risk 0.626613 pdq cancer genetics 0.575741 cancer genetic counseling 0.651461 cancer risk estimates 0.637042 family health history 0.593593	cancer risks 0.557149 cancer genetic counselling 0.564248 genetic tests 0.578519 genetic risk assignment 0.579316 family pathogenic variant 0.554782 genetic counseling 0.788203 risk breast cancer 0.592583 cancer susceptibility genes 0.585996 cancer family history 0.683221 pathogenic variants 0.673985 cancer risk estimate 0.588742 cancer risk calculations 0.583873 hereditary cancer risk 0.589876 cancer susceptibility 0.634338 breast cancer risk 0.620741 breast cancer 0.723734 cancer susceptibility gene 0.59457 family history 0.997369 genetic testing 0.827733 cancer risk 0.781419 hereditary cancer 0.608333 cancer 0.974451 risk 0.868438 Cancer Genetics Services 0.548203	CLICK HERE
1443	National Cancer Institute	Html	en	Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).	myeloma progression 0.386014 Lancet Oncol 0.385708 Rajkumar SV 0.402453 Myeloma Working Group 0.489063 stage multiple myeloma 0.418561 elderly multiple myeloma 0.451304 Br J Haematol 0.413842 Engl J Med 0.487061 newly diagnosed myeloma 0.445606 Myeloma Aredia 0.375106 monoclonal gammopathy 0.361847 symptomatic multiple myeloma 0.40517 Richardson PG 0.360951 Dimopoulos MA 0.411188 Myeloma Study Group 0.419959 multiple myeloma study 0.395149 Myeloma IX Trial 0.378652 NCRI Myeloma 0.373496 untreated multiple myeloma 0.466976 dexamethasone 0.382475 multiple myeloma 0.921615	European Myeloma Network 0.377714 autologous stem cell 0.362333 multiple myeloma patients 0.518428 Abstract 0.612448 Kyle RA 0.359131 therapy 0.359069 Clin Oncol 0.527005 International Myeloma Working 0.490739 Clin Lymphoma Myeloma 0.405037 novo multiple myeloma 0.392374 Myeloma Trialists 0.387014 refractory multiple myeloma 0.483265 advanced multiple myeloma 0.41891 Nordic Myeloma Study 0.418541 blood 0.413404 lenalidomide-refractory multiple myeloma 0.403712 plasma cell myeloma 0.383069 refractory myeloma 0.377628 active myeloma 0.392608 multiple myeloma refractory 0.398347 et al. 0.58043	CLICK HERE
1654	National Cancer Institute	Html	en	Gerson Therapy (PDQ®)–Health Professional Version	Expert-reviewed information summary about Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	complex regimen 0.484073 prescribed conventional regimen 0.48627 body 0.480118 treatment regimen 0.476762 New York City 0.503592 American Cancer Society 0.4659 normal metabolic state 0.454242 Gerson’s data 0.572285 coffee enemas 0.55048 Gerson Research Organization 0.580725 cancer information summary 0.482421 cancer therapies 0.454018 colorectal cancer 0.455812 diet regimen 0.532413 Gerson therapy 0.918805 patients 0.555703 cancer patients 0.512802 Gerson’s life 0.570445 Gerson regimen 0.719238 flaxseed oil 0.455436 diet group 0.469079 Charlotte Gerson Straus 0.587654 injectable crude liver 0.462964 gonzalez regimen 0.487953 potassium 0.46778	United States 0.4578 Gerson approach 0.560315 cancer cells 0.467412 5-year survival rate 0.480223 cancer cell biology 0.469353 Gerson regimen. 0.568736 A. Pancreatic enzymes 0.456434 potassium solution 0.46218 excess sodium 0.454821 Gerson Hospital 0.567697 Gerson approach. 0.560098 National Cancer Institute 0.466567 Desiccated liver capsules 0.461935 stage I–II patients 0.465698 New York 0.508367 Gerson segment 0.563678 pancreatic enzymes 0.529579 Gerson Institute 0.579619 healthy liver function. 0.462886 Gerson diet 0.622931 crude liver extract 0.544679 melanoma patients 0.45525 cancer 0.570183 Max Gerson 0.650691	CLICK HERE
1749	National Cancer Institute	Html	en	Helicobacter pylori and Cancer	A fact sheet about the relationship between H. pylori infection and gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and other cancers.	gastric malt lymphoma 0.326658 M. Gastric cancer 0.212884 H. pylori 0.843788 H. pylori colonization 0.258268 gastric cancer rates 0.221795 cagA-negative H. pylori 0.255803 Helicobacter pylori infection 0.310803 gastric adenocarcinoma 0.207225 Helicobacter pylori 0.602968 F. Helicobacter pylori 0.25223 noncardia gastric cancer 0.213325 non-cardia gastric cancer 0.587912	H. pylori infection 0.660511 caga-positive h. pylori 0.364356 gastric cancer 0.957743 M. Helicobacter pylori 0.251667 Helicobacter pylori CagA 0.252645 Helicobacter pylori seropositivity 0.402047 gastric cancer incidence 0.328991 Overall gastric cancer 0.233481 esophageal adenocarcinoma 0.208828 et al 0.379167 pylori infection rates 0.297929 gastric cardia cancer 0.470154	CLICK HERE
1860	National Cancer Institute	Html	es	Tratamiento del cáncer de laringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de laringe.	quimioterapia simultánea vs 0.243512 Long-term results 0.234954 radioterapia quizás 0.299585 Zhang Q 0.273545 T4b Enfermedad 0.236466 locally advanced larynx 0.275768 American Cancer Society 0.251609 Pfister DG 0.231071 laringectomía supraglótica 0.243655 Laryngeal Cancer Study 0.26012 nonsurgical treatment 0.254566 laryngeal cancer 0.299143 carcinoma among adult 0.240831 Radiat Oncol Biol 0.820998 DeVita VT Jr 0.253188 glottic larynx treated 0.257222 randomized trial comparing 0.232167 Forastiere AA 0.248924 radiation therapy 0.367315 Head Neck Surg 0.26729 Mendenhall WM 0.301851 with radiotherapy 0.237817 Head Neck 0.3155 cartílago tiroides 0.252905 squamous-cell carcinoma 0.25702	Pajak TF 0.243693 laryngeal carcinoma 0.232948 laringe t1 0.234844 radioterapia posoperatoria 0.379297 Otolaryngol Head Neck 0.267871 múltiples ganglios 0.238357 induction chemotherapy followed 0.233331 local control 0.243042 Clin Oncol 0.490486 Werning JW 0.23125 Oncol Biol Phys 0.857199 glottic carcinoma 0.24993 trial comparing 0.233043 versus concurrent chemoradiotherapy 0.238876 estadio iii 0.267441 neck cancer 0.97371 with or without 0.274489 ganglios linfáticos retrofaríngeos 0.238975 glottic carcinoma among 0.246513 locally advanced 0.370885 Cancer Study Group 0.254186 induction chemotherapy 0.25147 neck carcinoma 0.234046 squamous cell carcinoma 0.852023	CLICK HERE
1956	National Cancer Institute	Html	es	Tratamiento del timoma y carcinoma tímico (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del timoma y carcinoma tímico.	PDQ Tratamiento 0.893677 siguientes procedimientos 0.709695 presente sección 0.551021 carcinoma tímico recidivantes 0.908078 Physician Data Query 0.642942 Elabora glóbulos 0.610187 estadio iii 0.831613 libre uso 0.516662 rayos x 0.5901	historial médico 0.588571 estadio ivb 0.769721 escáner tep 0.596123 estadio iva 0.762108 National Cancer Institute 0.529434 siguientes riesgos 0.521125 siguientes estadios 0.586329 Instituto Nacional 0.56525	CLICK HERE
4249	National Cancer Institute	Html	en	Vaccine Therapy for Unresectable Chordoma	In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.	cancer vaccine 0.534872 normal adult tissue 0.528641 immune cell 0.47865 nonirradiated tumors 0.477218 overall response rate 0.514452 yeast cells 0.658954 Locally Advanced Chordoma 0.746841 targets brachyury 0.477414 chordoma 0.972044 tumor behavior 0.49462 adjuvant radiation therapy 0.576614 notochord cells 0.571698 small amounts 0.473793 radiation therapy 0.780229 brachyury vaccine 0.530311 tumor types 0.495175 NCI Center 0.485799 spine forms 0.477842 unresectable localized chordoma 0.680351 unresectable chordoma 0.714897 human brachyury protein 0.536106 experimental vaccine 0.525401 trial contact information 0.525243 United States 0.477985 Dr. Christopher Heery 0.538194	unirradiated tumor 0.498179 Drug Administration 0.474087 cancer cells 0.605559 irradiated tumor 0.517748 chordoma cells 0.729894 Treating Patients 0.48917 main treatment 0.476402 embryonic cells 0.554159 NCI Clinical Trials 0.525164 normal adult cells 0.609554 irradiated tumors 0.540538 tumor growth 0.505122 Cancer Research 0.485391 tumor cells 0.567871 Dr. Heery 0.484528 rare type 0.476522 chordoma patients 0.695766 chordoma tumors 0.646987 Chordoma Foundation 0.62992 yeast-brachyury vaccine 0.59967 Dendritic cells 0.55211 immune cells 0.606104 vaccine 0.650607 principal investigator 0.554808	CLICK HERE
4393	National Cancer Institute	Html	en	Care for Childhood Cancer Survivors	Survivorship care for children who have been treated for cancer is important. Get your child's treatment summary, survivorship plan, and recommendations on follow-up care clinics. Learn about long-term and late effects.	cancer treatment 0.326817 child needs 0.304086 follow-up care plan 0.413114 Planning fact sheet 0.303028 type 0.300894 health care team 0.507646 children 0.315621 follow-up care clinics 0.3448 survivorship clinics 0.2728 increased risk 0.28401 clinical trial 0.299772 survivorship care 0.448293 follow-up care visits 0.396149 child’s recovery 0.291653 Cancer Survivorship Care 0.352592 physical late effects 0.431203 survivorship care plan 0.433534 late side effects 0.29008 family health history 0.303512 health problems 0.288413 cognitive late effects 0.426207 Treatment dates 0.285186 radiation therapy 0.304846 Supportive care 0.276073 new routines 0.26175	long-awaited time 0.26767 late effects 0.939895 child 0.816649 treatment summary 0.334731 treatment information 0.286208 Emotional late effects 0.333335 survivor support groups 0.293019 treatment 0.559585 new phase 0.261152 post-traumatic stress disorder 0.292738 follow-up care plans 0.34673 children’s cancer 0.274057 palliative care 0.276488 Childhood Cancer 0.261784 Late Effects Directory 0.342069 child receive 0.286057 mental health support 0.300564 Survivorship care plans 0.341053 Family-based care 0.275482 child’s ability 0.286297 long-term side effects 0.358965 cancer 0.37733 follow-up care 0.618265 time 0.296976	CLICK HERE
15483	National Cancer Institute	Html	es	Cuidados de supervivencia para niños	null	leucemia linfocítica aguda 0.311324 tanta frecuencia 0.308963 Oncología Infantil 0.307626 familias sentimientos 0.30901 cuáles efectos tardíos 0.34751 efectos tardíos 0.975983	niño.  pida recomendaciones 0.316996 cuáles síntomas 0.30742 altas dosis 0.306279 determinados cánceres 0.306277 ¿por cuánto tiempo 0.310201 efectos cognitivos tardíos 0.415505	CLICK HERE